Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics
Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics
复制标题
DOI：
10.1016/j.drugalcdep.2010.05.007
复制
发表时间：
2010-11-01
影响因子：
4.2
通讯作者：
Li, C. S.
中科院分区：
文献类型：
--
作者：
Wilsey, B. L.;Fishman, S. M.;Li, C. S.
背景资料：本研究的主要目的是使用美国最大的电子处方监测计划（PMP）确定不同受控物质的多个供应商的患病率。次要目的是探索与涉及多个提供者的处方相关的患者和药物变量。PMP监测受控物质从药剂师到患者的最终分配。这种审查的主要目的是减少多个供应商的利用率为controlled substances.Methods：这是一个二级数据分析的加州PMP，控制物质利用审查和评估系统（CURES）。使用2007年收集的数据确定了多个供应商事件的流行率。使用一系列二项逻辑回归来预测每种通用类型的受控物质的多个处方者发作的比值比（OR）（即，阿片类药物，苯二氮卓类药物，兴奋剂，或减肥药（anorectic）使用人口统计学和处方variables.Results：阿片类药物的处方（12.8%）最常涉及多个供应商事件其次是苯二氮卓类药物（4.2%），兴奋剂（1.4%），和anorectic（0.9%），分别。最大的协会与多个供应商事件同时接受处方不同controlled substances.Conclusions：阿片类药物参与多个供应商处方比其他受控物质更频繁。使用多个供应商获得一类药物的可能性大大增加，因为患者从同一供应商或多个从业者那里获得了其他类别的受控物质。多重用药是一个信号，需要额外的警惕，以检测潜在的存在医生购物。出版社：Elsevier爱尔兰Ltd.
Background: The main objective of this study was to determine the prevalence of multiple providers for different controlled substances using the largest electronic prescription monitoring program (PMP) in the United States. A secondary objective was to explore patient and medication variables associated with prescriptions involving multiple providers. PMPs monitor the final allocation of controlled substances from pharmacist to patient. The primary purpose of this scrutiny is to diminish the utilization of multiple providers for controlled substances.Methods: This is a secondary data analysis of the California PMP, the Controlled Substance Utilization Review and Evaluation System (CURES). The prevalence of multiple provider episodes was determined using data collected during 2007. A series of binomial logistic regressions was used to predict the odds ratio (OR) of multiple prescriber episodes for each generic type of controlled substance (i.e., opioid, benzodiazepine, stimulant, or diet pill (anorectic) using demographic and prescription variables.Results: Opioid prescriptions (12.8%) were most frequently involved in multiple provider episodes followed by benzodiazepines (4.2%), stimulants (1.4%), and anorectics (0.9%), respectively. The greatest associations with multiple provider episodes were simultaneously receiving prescriptions for different controlled substances.Conclusions: Opioids were involved in multiple provider prescribing more frequently than other controlled substances. The likelihood of using multiple providers to obtain one class of medications was substantially elevated as patients received additional categories of controlled substances from the same provider or from multiple practitioners. Polypharmacy represents a signal that requires additional vigilance to detect the potential presence of doctor shopping. Published by Elsevier Ireland Ltd.